Cargando…

Persistent molecular remission of refractory acute myeloid leukemia with inv(16)(p13.1q22) in an elderly patient induced by cytarabine ocfosfate hydrate

The prognosis of relapsed acute myeloid leukemia (AML) in elderly patients is dismal, even if the AML exhibits a good prognostic karyotype, such as inv(16)(p13.1q22). We present a 72-year-old female with AML with inv(16)(p13.1q22) who suffered five episodes of relapse with temporary complete remissi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arahata, Masahisa, Shimizu, Yukihiro, Asakura, Hidesaku, Nakao, Shinji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332927/ https://www.ncbi.nlm.nih.gov/pubmed/25652695 http://dx.doi.org/10.1186/s13045-014-0100-6

Ejemplares similares

Oral cytarabine ocfosfate pharmacokinetics and assessment of leukocyte biomarkers in normal dogs
por: Zwueste, Danielle M., et al.
Publicado: (2023)

Identification and Prognostication of End-of-Life State Using a Japanese Guideline-Based Diagnostic Method: A Diagnostic Accuracy Study
por: Arahata, Masahisa, et al.
Publicado: (2023)

Antithrombotic therapies for elderly patients: handling problems originating from their comorbidities
por: Arahata, Masahisa, et al.
Publicado: (2018)

Three cases of systemic amyloidosis successfully diagnosed by subcutaneous fat tissue biopsy of the hip
por: Arahata, Masahisa, et al.
Publicado: (2016)

Blue Rubber Bleb Nevus Syndrome Complicated by Enhanced-Fibrinolytic-Type DIC: A Case Report
por: Yamada, Shinya, et al.
Publicado: (2021)

Constitutional pericentric inversion of chromosome 16, inv(16)(p13.1q22), mimicking acute myeloid leukemia
por: Ozaki, Shuji, et al.
Publicado: (2022)

A case of therapy-related acute myeloid leukemia with inv(16)(p13.1q22) after single low-dose iodine-131 treatment for thyroid cancer
por: Jeong, Ji Hun, et al.
Publicado: (2012)

A Case of Acute Myeloid Leukemia With inv(16)(p13.1q22);CBFB-MYH11 Presenting With Faggot Cells
por: Kim, Jung-Ah, et al.
Publicado: (2021)

A comprehensive intervention following the clinical pathway of eating and swallowing disorder in the elderly with dementia: historically controlled study
por: Arahata, Masahisa, et al.
Publicado: (2017)

Congestive heart failure associated with POEMS syndrome that was adequately distinguished from cardiac amyloidosis: a case report and literature review
por: Hagiwara, Goshi, et al.
Publicado: (2021)

Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report
por: Zhang, Wenyi, et al.
Publicado: (2021)

Acute myeloid leukemia with inv(16)(p13.1q22) and deletion of the 5’MYH11/3’CBFB gene fusion: a report of two cases and literature review
por: Lv, Lili, et al.
Publicado: (2020)

Novel Neurovascular Protective Agents: Effects of INV-155, INV-157, INV-159, and INV-161 versus Lipoic Acid and Captopril in a Rat Stroke Model
por: Connell, Barry J., et al.
Publicado: (2012)

Pulmonary Pleomorphic Carcinoma Mimicking Primary Sarcoma of the Neck: A Case Report and Literature Review
por: Ogawa, Daishi, et al.
Publicado: (2021)

Disseminated Langerhans cell histiocytosis associated with acute myeloid leukaemia: complete remission with daunorubicin and cytarabine
por: Hwang, Yu-Yan, et al.
Publicado: (2012)

Characteristics of hematologic malignancies with coexisting t(9;22) and inv(16) chromosomal abnormalities
por: Han, Eunhee, et al.
Publicado: (2014)

Aortic Aneurysm-associated Disseminated Intravascular Coagulation that Responded Well to a Switch from Warfarin to Rivaroxaban
por: Kadohira, Yasuko, et al.
Publicado: (2017)

Intermediate dose cytarabine improves survival and relapse-free rate compared with standard-dose cytarabine as post-remission treatment for acute myeloid leukemia: A retrospection study
por: Ye, Li, et al.
Publicado: (2021)

A Remarkable Remission: Treating HMA Refractory Transforming MDS with Single-Agent Low-Dose Cytarabine Leading to an Ongoing Six-Year OS
por: Palmer, David, et al.
Publicado: (2020)

Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemia
por: Canaani, Jonathan, et al.
Publicado: (2020)

Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trial
por: Konopleva, Marina Y., et al.
Publicado: (2022)

Classifying types of disseminated intravascular coagulation: clinical and animal models
por: Asakura, Hidesaku
Publicado: (2014)

Diversity of disseminated intravascular coagulation and selection of appropriate treatments
por: Asakura, Hidesaku
Publicado: (2020)

H->inv at ATLAS+CMS
por: Albert, Andreas
Publicado: (2021)

OsINV3 and Its Homolog, OsINV2, Control Grain Size in Rice
por: Deng, Xiaoshu, et al.
Publicado: (2020)

Incidental identification of inv(16)(p13.1q22)/CBFB–MYH11 variant transcript in a patient with therapy-related acute myeloid leukemia by routine leukemia translocation panel screen: implications for diagnosis and therapy
por: Quesada, Andrés E., et al.
Publicado: (2021)

Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes
por: Galtier, Jean, et al.
Publicado: (2021)

Over-Expression of CYP2E1 mRNA and Protein: Implications of Xenobiotic Induced Damage in Patients with De Novo Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFβ-MYH11
por: Kanagal-Shamanna, Rashmi, et al.
Publicado: (2012)

A Real-World Study on Clofarabine and Cytarabine Combination in Patients with Relapsed/Refractory Acute Myeloid Leukemia
por: Crobu, Valeria, et al.
Publicado: (2019)

A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia
por: Wang, Amy Y., et al.
Publicado: (2018)

Cladribine and cytarabine in children refractory high risk multisystem Langerhans cell histiocytosis
por: Wang, Wenqian, et al.
Publicado: (2023)

Overcoming bleeding events related to extracorporeal membrane oxygenation in COVID-19
por: Asakura, Hidesaku, et al.
Publicado: (2020)

COVID-19-associated coagulopathy and disseminated intravascular coagulation
por: Asakura, Hidesaku, et al.
Publicado: (2020)

Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC
por: Asakura, Hidesaku, et al.
Publicado: (2020)

Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm
por: Yamada, Shinya, et al.
Publicado: (2022)

Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination
por: Yamada, Shinya, et al.
Publicado: (2022)

Potential of heparin and nafamostat combination therapy for COVID‐19
por: Asakura, Hidesaku, et al.
Publicado: (2020)

Acute Myeloid Leukemia With Inv(16)(p13q22) Associated With Hidden Systemic Mastocytosis: Case Report and Review of Literature
por: Hilmi, Feryal Abbas Ibrahim, et al.
Publicado: (2017)

Faggot cells in therapy‐related acute myeloid leukemia with inv(16)
por: Vega González de Viñaspre, Ana, et al.
Publicado: (2020)

Glasdegib in combination with low-dose Cytarabine for the outpatient treatment of relapsed or refractory acute myeloid leukemia in unfit patients
por: Zucenka, Andrius, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_osjfiie0tsbhh6hjradlk88hfm